Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (3) , 251-257
- https://doi.org/10.1023/a:1008267904952
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVALThe Lancet, 1984
- The treatment of acute myelocytic leukemia in patients 30 years of age and youngerAmerican Journal of Hematology, 1982
- Short-term treatment for acute myelogenous leukaemia.BMJ, 1982
- HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1977
- Progress in the Treatment of Adults With Acute LeukemiaArchives of internal medicine (1960), 1976
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Estimation of the probability of an event as a function of several independent variablesBiometrika, 1967
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958